key facts: couple of big investment firms have recently added large at these prices........great entry point rite now........got overly punished by wall street on a slight fail in phase 2 testing, phase 3 trials will be setup so that thisd drug will very unlikely fail again....data showed that this chablyss the drug leads to 40% decrease in severe lupus cases in the long term. phase three starts early next year.
cash flush for a while, actively seeking partners at present.
its a high risk play but worth playing in imo.
check out stocktwits anth feed: couple of pro investors providing good data there to read for yourself, do youre own research, and let the markets do there job.
i wouldnt listen to the NUMBNUTS posting on here without relevant facts gd luck